It is therefore reasonable to deduce that the disruptions to podocyte insulin signaling, occurring in conditions of diabetes and systemic insulin resistance (26, 58), directly contribute toward disease, particularly in the early stages of DKD development (2, 59). This evidence concerns the gene INS and diabetic kidney disease.